Cargando…
TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial
BACKGROUND: Experimental studies suggest that angiotensin II plays a central role in the pathogenesis of abdominal aortic aneurysm. This trial aims to evaluate the efficacy of the angiotensin receptor blocker telmisartan in limiting the progression of abdominal aortic aneurysm. METHODS/DESIGN: Telmi...
Autores principales: | Morris, Dylan R., Cunningham, Margaret A., Ahimastos, Anna A., Kingwell, Bronwyn A., Pappas, Elise, Bourke, Michael, Reid, Christopher M., Stijnen, Theo, Dalman, Ronald L., Aalami, Oliver O., Lindeman, Jan H., Norman, Paul E., Walker, Philip J., Fitridge, Robert, Bourke, Bernie, Dear, Anthony E., Pinchbeck, Jenna, Jaeggi, Rene, Golledge, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482315/ https://www.ncbi.nlm.nih.gov/pubmed/26081587 http://dx.doi.org/10.1186/s13063-015-0793-z |
Ejemplares similares
-
Erratum to: ‘TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial’
por: Morris, Dylan R., et al.
Publicado: (2016) -
Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): study protocol for a randomised controlled trial
por: Rowbotham, Sophie E., et al.
Publicado: (2017) -
Randomized Placebo‐Controlled Trial Assessing the Effect of 24‐Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME‐2 Trial
por: Pinchbeck, Jenna L., et al.
Publicado: (2018) -
Short report: Experiences of Caregivers Participating in a Telehealth Evaluation of Development for Infants (TEDI)
por: Talbott, Meagan R., et al.
Publicado: (2022) -
Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth
por: Thanigaimani, Shivshankar, et al.
Publicado: (2022)